Trial intelligence / Profile preview

NOAAH: Newer vs Older Antihypertensives in African Patients

NCT01030458Phase 4Completed

Sponsor
KU Leuven
Start
Sep 2010
Primary completion
Mar 2012
Modality
Small Molecules
Countries
5
01

Overview

Phase 4, randomised, open-label trial of amlodipine and valsartan in hypertension (HTN) (2 arms), sponsored by KU Leuven. Primary endpoint: Sitting Systolic Blood Pressure on Automated Measurement at 6 months. Started Sep 2010; status: completed.

02

Drugs

amlodipinevalsartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT01030458.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01030458.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call